Li, H., Yang, L., Liu, L., Lai, X., Zhu, L., Zhao, K., Huang, H., Luo, Y. (2025). Inotuzumab ozogamicin as salvage therapy for refractory/relapsed B-cell acute lymphoblastic leukemia following the failure of chimeric antigen receptor T cell therapy and allogeneic hematopoietic stem cell transplantation. Blood. https://doi.org/10.1182/blood-2025-7810